Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 I, 2000, Pages 342-344

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CATARACT; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; EDITORIAL; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEROID THERAPY;

EID: 0034109837     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.2.16125_2     Document Type: Editorial

References (19)

1. Jeffery, P. K. 1998. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53:129-136.
2. Keatings, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
3. Barnes, P. J., S. Pedersen, and W. W. Busse. 1998. Efficacy and safety of inhaled corticosteroids: an update. Am. J. Respir. Crit. Care Med. 157: S1-S53.
4. Culpitt, S. V., J. A. Nightingale, and P. J. Barnes. 1999. Effect of fluticasone propionate on induced sputum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with COPD. Am. J. Respir. Crit. Care Med. 160:1635-1639.
5. Keatings, V. M., A. Jatakanon, Y.-M. Worsdel, and P. J. Barnes. 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
6. Confalonieri, M., E. Mainardi, R. Della Porta, S. Bernorio, L. Gandola, B. Beghe, and A. Spanevello. 1998. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 53:583-585.
7. Hattotuwa, K., T. Ansari, M. Gizycki, N. Barnes, and P. K. Jeffery. 1999. A double-blind placebo-controlled trial of the effect of inhaled corticosteroids on the immunopathology of COPD (abstract). Am. J. Respir. Crit. Care Med. 159:A523.
8. Dompeling, E., C. P. Van Schayck, J. Molema, H. Folgering, P. M. van Grusven, and C. van Weel. 1992. Inhaled beclomethasone improves the course of asthma and COPD. Eur. Respir. J. 5:945-952.
9. Kertjens, H. A. M., P. L. P. Brand, M. D. Hughes, N. J. Robinson, D. S. Postma, H. J. Sluiter, E. R. Bleeker, P. N. R. Dekuijzen, P. M. de Jong, H. J. J. Mengelers, S. E. Overbeek, and D. F. M. E. Schoonbrood. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N. Engl. J. Med. 327:1413-1419.
10. Watson, A., T. K. Lim, H. Joyce, and N. B. Pride. 1992. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responses in middle-aged smokers with mild airflow obstruction. Chest 101:350-355.
11. Weir, D. C., and P. S. Burge. 1993. Effects of high dose inhaled beclomethasone dipropionate 750 μg and 1500 μg twice daily and 40 mg oral prednisolone on lung function, symptoms and bronchial hyperresponsiveness in patients with non-asthmatic airflow obstruction. Thorax 48:309-316.
12. Burge, P. S. 1999. EUROSCOP, ISOLDE and the Copenhagen City Lung Study. Thorax 54:287-288.
13. Pauwels, R. A., C. G. Lofdahl, L. A. Laitinen, J. P. Schouten, D. S. Postma, N. B. Pride, and S. V. Ohlsson. 1999. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking: European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 340:1948-1953.
14. Vestbo, J., T. Sorensen, P. Lange, A. Brix, P. Torre, and K. Viskum. 1999. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 353:1819-1823.
15. Paggiaro, P. L., R. Dahle, I. Bakran, L. Frith, K. Hollingworth, and J. Efthimou. 1998. Multicenter randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 351:773-780.
16. Cox, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J. Immunol. 193:4719-4725.
17. Meagher, L. C., J. M. Cousin, J. R. Seckl, and C. Haslett. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156:4422-4428.
18. Nightingale, J. A., D. F. Rogers, K. F. Chung, and P. J. Barnes. 1999. Effect of inhaled budesonide on the response to inhaled ozone in normal subjects. Am. J. Respir. Crit. Care Med. (In press)
19. Barnes, P. J. 1998. New therapies for chronic obstructive pulmonary disease. Thorax 53:137-147.